CPR Pharma Services has developed a solid reputation for delivering clinical studies; on time and on budget. Our professional customer service and the speed and quality of our work sets us apart from our competitors; which is why we enjoy an 85% rate of repeat business from satisfied sponsors. We are the only Australian CRO to offer a full suite of in-house services including clinical project management and monitoring, data services, pharmacokinetics, statistics and report writing through to bio-analytical services including ground-breaking work in biomarker and peptide studies. Our Fast2PhaseOne service enables clients to make a fast Go / No Go decision for their first-in-human trials thanks to Australias regulatory advantages including: o streamlined Clinical Trials Notification (CTN) Scheme o full Good Manufacturing Practice (GMP) material not required o no Investigational New Drug (IND) application required Together with our assistance to foreign clients interested in gaining access to the Australian R&D Tax Incentive (including current US-based clients), CPRs offering is unique in the industry and strengthens its international competitiveness while providing a cost-effective alternative to contract research organisations in Europe and the US. Headquartered in South Australia, CPR Pharma Services operates within a stringent ICH GCP / GLP environment overseen by our internationally recognised scientific staff and has been inspected by both the FDA and EMA. For more information, visit www.cprpharma.com.
CPR Pharma Services has developed a solid reputation for delivering clinical studies; on time and on budget. Our professional customer service and the speed and quality of our work sets us apart from our competitors; which is why we enjoy an 85% rate of repeat business from satisfied sponsors. We are the only Australian CRO to offer a full suite of in-house services including clinical project management and monitoring, data services, pharmacokinetics, statistics and report writing through to bio-analytical services including ground-breaking work in biomarker and peptide studies. Our Fast2PhaseOne service enables clients to make a fast Go / No Go decision for their first-in-human trials thanks to Australias regulatory advantages including: o streamlined Clinical Trials Notification (CTN) Scheme o full Good Manufacturing Practice (GMP) material not required o no Investigational New Drug (IND) application required Together with our assistance to foreign clients interested in gaining access to the Australian R&D Tax Incentive (including current US-based clients), CPRs offering is unique in the industry and strengthens its international competitiveness while providing a cost-effective alternative to contract research organisations in Europe and the US. Headquartered in South Australia, CPR Pharma Services operates within a stringent ICH GCP / GLP environment overseen by our internationally recognised scientific staff and has been inspected by both the FDA and EMA. For more information, visit www.cprpharma.com.
Company Information
- Industry
- Pharmaceuticals
- Company Type
- Privately Held
- Founded
- unknown
- Employee Range
- 51-200
- Revenue Range
- Not available
Location
- Address
- City
- Region
- Postal Code
- Country
- Australia